跳到正文
cccskills
免费在 GitHub 公开

endo-assess-basal-settings-rate-testing

Evaluates basal insulin rates through basal rate testing across different time periods and adjusts as indicated. Triggered by clinician orders to 'Perform basal rate test to verify pump settings' or 'Check basal rates during periodic pump review'.

中文简介正在准备中。当前显示原文说明。

查看安装方法

包含的文件(1)

  • SKILL.md3.0 KB

SKILL.md(原文)

安装前可以查看交给 AI 代理的指令内容。

Assess basal settings via basal rate testing

STEP 1 — Gather Information

Collect recent CGM or SMBG glucose profiles (including overnight, pre‑meal, post‑meal), current basal rate schedule, recent hypoglycemia/hyperglycemia events, and confirm patient ability to safely fast for testing periods.
Action: Proceed to assess safety and eligibility for basal rate testing.

STEP 2 — Rule In / Rule Out

Determine if basal rate testing is safe: no recent severe hypoglycemia, patient can monitor glucose frequently, not pregnant or acutely ill, and has rapid‑acting carbohydrate available.

  • If unsafe → Rule out basal rate testing; pursue alternative assessment (e.g., review pump downloads, consider sensor‑guided adjustments).
  • If safe → Rule in basal rate testing; schedule test periods (typically overnight, pre‑breakfast, pre‑lunch, pre‑dinner).
    Action: Either rule out and document rationale, or rule in and prepare for testing.

STEP 3 — Classify or Stratify

Analyze glucose trends during each basal test period to classify pattern:

  • Stable (change ≤10 mg/dL) → no adjustment needed.
  • Hypoglycemic trend (fall >10 mg/dL) → basal too high.
  • Hyperglycemic trend (rise >10 mg/dL) → basal too low.
  • Dawn phenomenon (early‑morning rise) → consider increased basal overnight.
    Action: Identify basal adjustment direction and magnitude based on observed glucose drift.

STEP 4 — Decide

Adjust basal rates by 10‑20% for the identified periods (decrease for hypoglycemia, increase for hyperglycemia); if stable, hold current rate. Document changes, educate patient on signs of over/under‑basal, and plan follow‑up review.
Action: Implement basal rate adjustment and schedule reassessment in 1‑2 weeks.

Clinical Guardrails / Mimics / Pitfalls

Do not test during illness, alcohol use, or altered basal‑to‑bolus ratios; avoid >20% basal change per adjustment; ensure patient can treat hypoglycemia promptly; confirm basal rates remain physiologic (typically 40‑60% of total daily dose); beware of mistaking post‑prandial effects for basal needs.

Concrete Clinical Example

A 45‑year‑old with T1DM using CSII reports fasting glucose 180 mg/dL; overnight basal test shows a 30 mg/dL rise from 02:00–06:00; increase basal rate 15% during that window; follow‑up shows fasting glucose 130 mg/dL.

Source: Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline, Anne L. Peters et al., 2016, DOI: 10.1210/jc.2016-2534

TODO: consider adding scripts/calc.py for the endo-assess-basal-settings-rate-testing calculator

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问,或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护,适用 Google 的隐私权政策和服务条款。

同一仓库的技能

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题